Abstract
Introduction
Genome-wide association studies (GWASs) have found a wealth of genetic associations with diseases and traits. The functional meaning of these associations remains largely unknown.
This may be due to: i) the associated variant being in Linkage Disequilibrium (LD) with, but distinct from, the causal one, ii) the partner causal gene of the variant not necessarily being the nearest to it and, iii) lack of longitudinal assessments of gene function 1 .
A useful tool in this elucidation effort is the class of methods under the Mendelian Randomization (MR) heading [2] [3] [4] [5] . The bare bones of the MR idea are that for an exposure (X)
to be a causal influence on an outcome (Y), we, under certain assumptions, expect there to be a genetic variant (Z) that modulates X to likewise affect Y. Information about Z can then be used as an instrument to assess the causal effect of X on Y, despite confounding; in which case Z is called an instrumental variable (IV) for the effect of X on Y.
Our illustrative example involves data from Multiple Sclerosis (MS) multiplex families, which we use to assess the possible disease-causing effect of four selected proteins, selected in the light of results from a GWAS by the International Multiple Sclerosis Genetic Consortium (IMSGC) 6 . Thus, in our analysis, X represents the plasma level of a protein of interest, and Y is a 0-1 indicator of disease status, whereas Z is the instrumental information provided by Immunochip data. We extend the Bayesian MR method of Berzuini et al. 7 to deal with pedigree data, by allowing an estimate of the kinship matrix 8 to enter the specification of the multivariate distribution of Y, so as to incorporate pedigree-induced relatedness in the model. Moreover, our model enhances the ability of the method by Berzuini et al. 7 to deal with weakly correlated IVs, for a more informative analysis of the finely mapped Immunochip data. This is done by acknowledging correlation among IVs in the prior distribution of the pleiotropic effects, specifically by using a g-prior 9 .
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We jointly analyse two samples of individuals. One of them, which we shall referred to as Sample 1, contains individuals with a complete set of values for X, Y, and Z. The remaining individuals, which we label as Sample 2, have no measured value for X. From a Bayesian point of view, the distinction between samples is artificial, as we may just think in terms of a single sample with some missing exposures, to be treated as additional parameters to be estimated from the data, as is customary in Bayesian analysis.
Methods

Sample description
MS patients were ascertained through the case register established in 1995 in the province of Nuoro, Sardinia, Italy. Cases were diagnosed according to Poser's criteria 10 .
Twenty extended MS multiplex pedigrees were selected for the analysis for a total of N=936 individuals (98 cases and 838 unaffected relatives) which were used to calculate the kinship matrix. Two subsets of the N individuals were analysed: Sample 1 (consisting of N1 individuals) with a completely observed X, Y and Z, and Sample 2 (consisting of N2 individuals) with observed Y and Z, and unobserved X, with N=N1+N2.
Genotyping data
Genotyping data were obtained by using Immunochip Illumina Infinium HD custom array, designed for fine mapping of 184 established autoimmune loci 6 .
The quality control-filtered dataset included 127. 
where the symbol ~ is a shorthand for "is distributed as", Normal(w,q) and MVNormal(w,q)
respectively denote normal and multivariate normal distribution with mean w and (co)variance (matrix) q, α ≡ (α1, ... , αJ ) is the vector of i-e associations; ≡ (β1, ... , βJ ) the vector of pleiotropic effects, and θ is the causal effect of interest, i.e., the change in log-odds of disease corresponding to an interventional unit change in X. Let the total effect for the generic, jth, instrument be defined as = + , where is the indirect effect and the direct effect of the IV, on a log-odds scale.
A graphical representation of the model, which uses the Winbugs "plate" formalism 20 , is given in Figure 1 .
We complete the Bayesian model with the following prior specifications:
• follows a (0, 2 ) prior, where the unknown quantity is a priori distributed as a half-Cauchy distribution on the positive reals with location 0 and scale 1,
• the individual-specific values of U and follow independent standard normal priors,
• the parameters , are assigned (0,0.25) priors,
• the vector β is a priori MVNormal(0, 2 ) with given matrix A=( ) −1 , and with parameters and discussed in the next section.
A discussion of the identifiability properties of this model in the special case where Ʃ is diagonal and β subject to an independence shrinkage prior is given in Berzuini et al. 7 .
The vector β and the parameter are also unidentifiable from the likelihood, but they have
proper posteriors under the above model when β is subject to a shrinkage prior, this latter translating the biologically plausible assumption that some instruments exert no pleiotropic effect on the outcome. In Berzuini et.al. 7 the shrinkage is obtained by a horseshoe prior that takes the β to be independent. In contrast, our model explicitly acknowledges IV correlation by taking β to follow the g-prior 21 discussed in the next section. A further novelty in our proposal is taking the vector of logit probabilities of disease to have a multivariate normal distribution that accounts for the pedigree-induced individual-individual correlations implicit in the kinship matrix, Ʃ.
Modelling instrument-instrument correlations via g-priors
In many applications, it is customary to assume that an unknown subset of pleiotropic effects has value zero. This (often plausible) assumption is sufficient under the above model to obtain a proper posterior distribution for the parameter of inferential interest, θ. In Berzuini et.al. 7 , these considerations justify the use of an independence shrinkage prior for β. But in those situations where we have an ensemble of weakly correlated IVs, a more appropriate choice of 9 a prior for β is a prior that captures the idea of a possible correlation among its component.
We here propose the use of a g-prior for β. Following Liquet et al. 21 , we specify the g-prior as:
, where 2 follows a priori an inverse Gamma distribution with chosen hyperparameters a, b, although in our final model we fix 2 = 1, as suggested in Marin and Robert 23 .
is defined as:
= where the scaling parameter , that governs the selection of variables, is assigned an inverse Gamma prior with hyperparameters 1 and N1. By imposing the β coefficients a correlation structure that mirrors the likelihood, the g-prior, acts as a shrinkage device, it discourages simultaneous inclusion in the model of instruments that are positively correlated 21 .
Computational method
Our Bayesian analyses were performed by using the Hamiltonian Markov chain Monte Carlo (MCMC) facilities offered by the STAN language 24 (http://mc-stan.org/) via the Rstan R interface 25 . Relevant STAN code is given in the Supplementary Material.
We checked the goodness of fit of each model by comparing outcome distribution statistics (posterior mean and standard deviation) from datasets simulated from the entertained model with the corresponding observed statistics in the spirit of Gelman's predictive checks 26 .
Frequentist Mendelian Randomization
For purposes of comparison, we re-analysed the data by using the following frequentist MR methods, without altering the set of IVs: Inverse-Variance Weighted estimator (IVW) 27, 28 , 29, 30 and Weighted Median Estimator (WME) 28, 31 .
MR-Egger Regression estimator (MR-ER)
These methods, as provided by the MendelianRandomization R package 32 , are able to work from summary statistics, and assume the instruments to be independent. Summary statistics from the regressions of each candidate protein level on each IVs were obtained from Sample 1. Summary statistics from the regressions of the MS indicator on selected IVs, in the form of estimated log-odds ratios, were obtained from a previous study of ours 11 . Table 1 shows for each protein the total number of selected IVs (see Supplementary Table SM2 for details). Table 2 reports the results obtained by using the Bayesian method of Berzuini et al. 7 (Analysis 1) and those by using the same method with g-priors (Analysis 2).
Results
Selection of IVs
Results of Bayesian Mendelian Randomization
For each protein and for each analysis, the posterior mean for the causal effect, ̂, its corresponding 95% posterior Credible Interval (CI) and its standard deviation (sd) are reported. The two analyses agree on the causal effect θ of each candidate protein having a negative point estimate and on the posterior distribution for the causal effects of IL12A and STAT4 being well separated from the null. According to Analysis 2, ̂ is significantly different from the null also for EVI5 and IRF8 proteins. Recall that θ represents the causal effect on MS on a log-odds ratio scale. Posterior estimates did not vary dramatically across the two analyses, and convergence of the Markov chain was satisfactory in both of them. Table 3 reports the results of the frequentist MR analysis for the four candidate proteins.
Results from frequentist Mendelian Randomization
According to this analysis, IL12A exhibits a significant and consistent causal effect on MS This paper addresses and combines the three mentioned issues.
MR methods have been frequently applied to the study of high-level exposures, such as obesity 33, 34 . Our illustrative study turns the attention to disease-causing agents that operate at an earlier stage of the causal chain: the proteins. By focusing on proteins, we are professing interest in exposures that are (in some sense) closer to the genetic instruments. We would hardly be able to judge how successful MR can be in this application context without experimenting on real data, as we do in this paper. Another idea in this paper, which, to the best of our knowledge, is new in MR literature, is to apply the method to pedigrees. Sample individuals belonging to the same family tend to display a lower degree of genetic heterogeneity, especially if they are drawn from a founder and isolated population as Sardinian, as in our study. One reason being that, in this case, the individuals also share a large portion of environmental variability. The low heterogeneity facilitates detection of causality at the level of proteins. Another reason for our interest in family data is that they reveal, to a larger extent than other sources, the underlying kinship structure of the studied individuals. By incorporating this information in the model, as we have done, we (to some degree) reduce the biasing effect of unobserved gene-related confounders. Researchers aware of the vulnerability of MR to unobserved confounding and to untestable violations of the assumption of instrument-confounder independence cannot underappreciate that feature.
The collection of variants that we chose to act as IVs in our analyses can be subdivided in two groups, according as that variant is located in the encoding gene, in which case we say it is acting in cis, or in the distal region of the gene, in which case we say it is acting in trans. Graph should be interpreted as a conditional independence directed acyclic graph according to 22 . In this figure the parameters that enter the distribution specification of an unobservable variable are represented as direct parents of that variable. 
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